Naar homepage     
Chronische Cerebro-Spinale Veneuze Insufficiëntie
Aanmelden op het CCSVI.nl forum 		Lees Voor (ReadSpeaker)    A-   A+
Over CCSVI.nl | Zoeken | Contact | Forum
CCSVI.nl is onderdeel van de
Franz Schelling Website
meer informatie
  
http://www.businessweek.com/news/2011-12-12/novartis-confirms-patient-died-after...
Tuesday, December 13, 2011 1:29 AM | Venöse Multiple Sklerose, CVI & SVI, CCSVI Volg link
http://www.businessweek.com/news/2011-12-12/novartis-confirms-patient-died-after-starting-gilenya-therapy.html


Novartis Confirms Patient Died After Starting Gilenya Therapy - Businessweek
www.businessweek.com
Novartis AG said a multiple sclerosis patient died on Nov. 23 after starting treatment with Gilenya, the Basel, Switzerland-based drugmaker’s pill for MS.